International Journal of Cardiology
Volume 139, Issue 2 , Pages 150-158 , 4 March 2010

Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules

  • John Lekakis

      Affiliations

    • 2nd Department of Cardiology, Attikon Hospital, University of Athens, School of Medicine, Athens, Greece
  • ,
  • Ignatios Ikonomidis

      Affiliations

    • 2nd Department of Cardiology, Attikon Hospital, University of Athens, School of Medicine, Athens, Greece
    • Corresponding Author InformationCorresponding author. 19 Perikleous Str, 14343, Athens, Greece. Tel.: +30 6944805732; fax: +30 210 7299201.
  • ,
  • Zoi Papoutsi

      Affiliations

    • Department of Biological Chemistry, University of Athens, School of Medicine, Athens, Greece
  • ,
  • Paraskevi Moutsatsou

      Affiliations

    • Department of Biological Chemistry, University of Athens, School of Medicine, Athens, Greece
  • ,
  • Maria Nikolaou

      Affiliations

    • 2nd Department of Cardiology, Attikon Hospital, University of Athens, School of Medicine, Athens, Greece
  • ,
  • John Parissis

      Affiliations

    • 2nd Department of Cardiology, Attikon Hospital, University of Athens, School of Medicine, Athens, Greece
  • ,
  • Dimitrios Th. Kremastinos

      Affiliations

    • 2nd Department of Cardiology, Attikon Hospital, University of Athens, School of Medicine, Athens, Greece

Received 14 January 2008 ,Revised 20 September 2008 ,Accepted 12 October 2008.

References 

  1. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction:impact on 6-month survival. JAMA. 1993;270:1819–1825
  2. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol. 2001;88:337–341
  3. Carney RM, Rich MW, Tevelde A, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol. 1987;60:1273–1275
  4. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580–592
  5. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol. 2001;88:196–198
  6. Sherwood A, Hinderliter AL, Watkins LL, Waugh RA, Blumenthal JA. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol. 2005;46:656–659
  7. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894–1898
  8. Glassman AH, O'Connor CM, Calliff RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–709
  9. Serebruany VL, Suckow RF, Cooper TB, et al. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry. 2005;162:1165–1170
  10. Blankenberg S, Rupprecht HJ, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336–1342
  11. Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis. 2008;199(1):3–11
  12. Himmerich H, Fulda S, Linseisen J, et al. Depression, comorbidities and the TNF-alpha system. Eur Psychiatry. 2008;23:421–429
  13. Parissis JT, Adamopoulos S, Rigas A, et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol. 2004;15(94):1326–1328
  14. Wu D, Koga T, Martin KR, Meydani M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atheroslerosis. 1999;147(2):297–307
  15. Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55(4):820–829
  16. Zhang WJ, Stocker R, McCall MR, Forte TM, Frei B. Lack of inhibitory effect of HDL on TNF alpha-induced adhesion molecule expression in human aortic endothelial cells. Atheroslerosis. 2002;165(2):241–249
  17. Denizof F, Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrozolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89(2):271–277
  18. Maurer Spurej E. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection CMLS. Cell Mol Life Sci. 2005;62:159–170
  19. Zapolska-Downar D, Zapolski-Downar A, Markiewski M, Ciechanowicz A, Kaczmarczyk M, Naruszewicz M. Selective inhibition by α-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochem Biophys Res Comm. 2000;274:609–615
  20. Parissis JT, Nikolaou M, Farmakis D, et al. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart. 2008;94:585–589
  21. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384–416
  22. Zung WW. A self-rating depression scale. Arch GenPsychiatry. 1965;12:63–70
  23. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  24. Monaco C, Paleolog E. Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res. 2004;61(4):671–682
  25. Glibetic M, Samlalsingh-Parker J, Raykova V, Ofenstein J, Aranda JV. Group B Streptococci and inducible nitric oxide synthase: modulation by nuclear factor kappa B and ibuprofen. Semin Perinatol. 2001;25(2):65–69
  26. Vo PA, Lad B, Tomlinson JA, Francis S, Ahluwalia A. Autoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function. J Biol Chem. 2005;280(8):7236–7243
  27. Stefano GB, Peter D. Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications. Med Sci Monit. 2001;7:1066–1074
  28. Lara N, Archer SL, Baker GB, LeMelledo JM. Paroxetine-induced increase in metabolic end-products of nitric oxide. J Clin Psychopharmacol. 2003;23:641–645
  29. Khan BV, Harrisson DG, Olbrych MT, Alexander RW, Medford RM. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA. 1996;93:9114–9118
  30. Frishman WH. Biologic markers as predictors of cardiovascular disease. Am J Med. 1998;104(6A):18S–27S
  31. Marfella R, Esposito K, Giunta R, et al. Circulating adhesion molecules in humans. Role of hyperglycemia and hyperinsoulinemia. Circulation. 2000;101:2247–2251
  32. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314–1319
  33. Zouridakis E, Avangas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation. 2004;110:1747–1753
  34. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome. Insights from therapeutic interventions. J Am Coll Cardiol. 2005;46:1978–1985
  35. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(08)01069-3

doi: 10.1016/j.ijcard.2008.10.010

International Journal of Cardiology
Volume 139, Issue 2 , Pages 150-158 , 4 March 2010